Cannara Biotech (OTCMKTS:CNBTF) Stock Price Up 2% – Should You Buy?

Cannara Biotech (OTCMKTS:CNBTF) shares traded up 2% during trading on Friday . The company traded as high as $1.37 and last traded at $1.37. 15,900 shares traded hands during mid-day trading, a decline of 52% from the average session volume of 33,127 shares. The stock had previously closed at $1.3430.

Cannara Biotech Price Performance

The firm has a 50-day moving average of $1.34 and a two-hundred day moving average of $1.28.

Cannara Biotech Holdings Inc (OTCMKTS:CNBTF) is a biotechnology and natural health company focused on the development, production and distribution of plant-derived formulations, including cannabinoid-based products. Headquartered in Canada, the company integrates research and development with large-scale extraction and formulation processes to serve the pharmaceutical, cosmetic and wellness industries.

The company’s offerings comprise high-purity botanical extracts, nutraceutical ingredients and cosmetic actives developed using proprietary extraction and purification techniques.